Interpace Diagnostics Group, Inc.

Interpace Diagnostics develops molecular diagnostic tests. You can be assured that all of the molecular tests we offer are driven by rigorous, validated science.We power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. The unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

Bank Name Interpace Diagnostics Group, Inc.
Stock Exchange NASDAQ
Symbol IDXG
Sector Healthcare
Industry Medical/Dental Instruments
Country United States
World Region Amarica
CEO Mr. Jack E. Stover
Employees 75
Registered Year 1986